CXCL10 and rheumatoid arthritis: In humans, the blockade of CXCL10 showed positive effects on the progression of rheumatoid arthritis, indicating a therapeutic approach in blocking the CXCL10-CXCR3 axis not only in experimental mouse models but also in human disease [54].